Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker STIM
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 13, 2026 | Jorey Chernett 10% owner | STIM Neuronetics, Inc. | Sale | 2.19M | $1.15 | $2.5M Sale | Form 4 ↗ |
| Nov 12, 2026 | Jorey Chernett 10% owner | STIM Neuronetics, Inc. | Sale | 706,840 | $1.43 | $1.0M Sale | Form 4 ↗ |
| Nov 11, 2026 | Jorey Chernett 10% owner | STIM Neuronetics, Inc. | Sale | 86,757 | $1.61 | $139.7K Sale | Form 4 ↗ |
| Nov 9, 2026 | Jorey Chernett 10% owner | STIM Neuronetics, Inc. | Buy | 40,000 | $1.99 | $79.6K Buy | Form 4 ↗ |
| Nov 9, 2026 | Jorey Chernett 10% owner | STIM Neuronetics, Inc. | Sale | 103,959 | $2.06 | $214.2K Sale | Form 4 ↗ |
| Nov 6, 2026 | Jorey Chernett 10% owner | STIM Neuronetics, Inc. | Sale | 250,804 | $2.39 | $599.4K Sale | Form 4 ↗ |
| Oct 30, 2026 | Jorey Chernett 10% owner | STIM Neuronetics, Inc. | Buy | 18,000 | $2.27 | $40.9K Buy | Form 4 ↗ |
| Aug 14, 2026 | Jorey Chernett 10% owner | STIM Neuronetics, Inc. | Buy | 14,000 | $3.16 | $44.2K Buy | Form 4 ↗ |
| Jul 14, 2026 | Jorey Chernett 10% owner | STIM Neuronetics, Inc. | Buy | 35,000 | $1.78 | $62.3K Buy | Form 4 ↗ |
| May 19, 2026 | Jorey Chernett 10% owner | STIM Neuronetics, Inc. | Buy | 100,000 | $1.17 | $117.0K Buy | Form 4 ↗ |
| May 12, 2026 | Jorey Chernett 10% owner | STIM Neuronetics, Inc. | Buy | 475,000 | $1.34 | $636.5K Buy | Form 4 ↗ |
| Apr 21, 2026 | Jorey Chernett 10% owner | STIM Neuronetics, Inc. | Buy | 100,000 | $1.51 | $151.0K Buy | Form 4 ↗ |
| Apr 20, 2026 | Jorey Chernett 10% owner | STIM Neuronetics, Inc. | Buy | 100,000 | $1.58 | $158.0K Buy | Form 4 ↗ |
| Mar 30, 2026 | Jorey Chernett 10% owner | STIM Neuronetics, Inc. | Buy | 385,442 | $1.25 | $481.8K Buy | Form 4 ↗ |
| Mar 27, 2026 | Jorey Chernett 10% owner | STIM Neuronetics, Inc. | Buy | 500,000 | $1.35 | $675.0K Buy | Form 4 ↗ |
| Mar 26, 2026 | Jorey Chernett 10% owner | STIM Neuronetics, Inc. | Buy | 25,000 | $1.44 | $36.0K Buy | Form 4 ↗ |
| Mar 25, 2026 | Jorey Chernett 10% owner | STIM Neuronetics, Inc. | Buy | 125,000 | $1.40 | $175.0K Buy | Form 4 ↗ |
| Mar 20, 2026 | Jorey Chernett 10% owner | STIM Neuronetics, Inc. | Buy | 169,472 | $1.41 | $239.0K Buy | Form 4 ↗ |
| Mar 19, 2026 | Steven Pfanstiel Former EVP, CFO and Treasurer | STIM Neuronetics, Inc. | Sale | 8,569 | $1.34 | $11.5K Sale | Form 4/A ↗ |
| Mar 19, 2026 | Keith J. Sullivan | STIM Neuronetics, Inc. | Sale | 46,289 | $1.34 | $62.0K Sale | Form 4 ↗ |
| Mar 19, 2026 | William Andrew Macan EVP, CLO and CS | STIM Neuronetics, Inc. | Sale | 16,005 | $1.34 | $21.4K Sale | Form 4 ↗ |
| Mar 19, 2026 | Jorey Chernett 10% owner | STIM Neuronetics, Inc. | Buy | 450,000 | $1.33 | $598.5K Buy | Form 4 ↗ |
| Mar 18, 2026 | Jorey Chernett 10% owner | STIM Neuronetics, Inc. | Buy | 607,400 | $1.35 | $820.0K Buy | Form 4 ↗ |
| Mar 17, 2026 | Jorey Chernett 10% owner | STIM Neuronetics, Inc. | Buy | 531,000 | $1.16 | $616.0K Buy | Form 4 ↗ |
| Mar 4, 2026 | William Andrew Macan EVP, CLO and CS | STIM Neuronetics, Inc. | Sale | 609 | $1.34 | $816 Sale | Form 4 ↗ |
| Feb 26, 2026 | William Andrew Macan EVP, CLO and CS | STIM Neuronetics, Inc. | Sale | 3,427 | $1.35 | $4,626 Sale | Form 4 ↗ |
| Feb 26, 2026 | Keith J. Sullivan President and CEO, Director | STIM Neuronetics, Inc. | Sale | 8,452 | $1.35 | $11.4K Sale | Form 4 ↗ |
| Feb 12, 2026 | Keith J. Sullivan President and CEO, Director | STIM Neuronetics, Inc. | Sale | 33,847 | $1.65 | $55.8K Sale | Form 4 ↗ |
| Feb 12, 2026 | William Andrew Macan EVP, CLO and CS | STIM Neuronetics, Inc. | Sale | 14,120 | $1.65 | $23.3K Sale | Form 4 ↗ |
| Feb 10, 2026 | William Andrew Macan EVP, CLO and CS | STIM Neuronetics, Inc. | Sale | 3,485 | $1.55 | $5,402 Sale | Form 4 ↗ |
| Feb 10, 2026 | Keith J. Sullivan President and CEO, Director | STIM Neuronetics, Inc. | Sale | 40,976 | $1.55 | $63.5K Sale | Form 4 ↗ |
| Aug 8, 2025 | Madryn Asset Management, LP 10% owner | STIM Neuronetics, Inc. | Sale | 381,640 | $3.72 | $1.4M Sale | Form 4 ↗ |
| Aug 8, 2025 | Madryn Asset Management, LP 10% owner | STIM Neuronetics, Inc. | Sale | 2.93M | $3.72 | $10.9M Sale | Form 4 ↗ |
| Aug 8, 2025 | Madryn Asset Management, LP 10% owner | STIM Neuronetics, Inc. | Sale | 192,806 | $3.72 | $717.2K Sale | Form 4 ↗ |
| May 13, 2025 | Stephen Furlong EVP, CFO and Treasurer | STIM Neuronetics, Inc. | Sale | 6,540 | $4.16 | $27.2K Sale | Form 4 ↗ |
| May 12, 2025 | Stephen Furlong EVP, CFO and Treasurer | STIM Neuronetics, Inc. | Sale | 193,460 | $4.27 | $826.1K Sale | Form 4 ↗ |
| Mar 4, 2025 | Stephen Furlong EVP, CFO and Treasurer | STIM Neuronetics, Inc. | Sale | 1,867 | $4.48 | $8,364 Sale | Form 4 ↗ |
| Mar 4, 2025 | William Andrew Macan EVP, GC, CCO and CS | STIM Neuronetics, Inc. | Sale | 377 | $4.48 | $1,689 Sale | Form 4 ↗ |
| Feb 19, 2025 | Keith J. Sullivan President and CEO, Director | STIM Neuronetics, Inc. | Sale | 24,440 | $4.70 | $114.9K Sale | Form 4 ↗ |
| Feb 18, 2025 | Keith J. Sullivan President and CEO, Director | STIM Neuronetics, Inc. | Sale | 25,934 | $4.41 | $114.4K Sale | Form 4 ↗ |
| Feb 14, 2025 | William Andrew Macan EVP, GC, CCO and CS | STIM Neuronetics, Inc. | Sale | 18,965 | $4.11 | $77.9K Sale | Form 4 ↗ |
| Feb 14, 2025 | Stephen Furlong EVP, CFO and Treasurer | STIM Neuronetics, Inc. | Sale | 17,307 | $4.11 | $71.1K Sale | Form 4 ↗ |
| Feb 12, 2025 | Stephen Furlong EVP, CFO and Treasurer | STIM Neuronetics, Inc. | Sale | 10,845 | $3.83 | $41.5K Sale | Form 4 ↗ |
| Feb 12, 2025 | William Andrew Macan EVP, GC, CCO and CS | STIM Neuronetics, Inc. | Sale | 12,175 | $3.83 | $46.6K Sale | Form 4 ↗ |
| Feb 10, 2025 | William Andrew Macan EVP, GC, CCO and CS | STIM Neuronetics, Inc. | Sale | 1,970 | $3.28 | $6,462 Sale | Form 4 ↗ |
| Feb 10, 2025 | Keith J. Sullivan President and CEO, Director | STIM Neuronetics, Inc. | Sale | 40,992 | $3.28 | $134.5K Sale | Form 4 ↗ |
| Feb 10, 2025 | Stephen Furlong EVP, CFO and Treasurer | STIM Neuronetics, Inc. | Sale | 14,836 | $3.28 | $48.7K Sale | Form 4 ↗ |
| Oct 8, 2024 | Stephen Furlong EVP, CFO and Treasurer | STIM Neuronetics, Inc. | Sale | 1,368 | $0.82 | $1,122 Sale | Form 4 ↗ |
| Oct 8, 2024 | William Andrew Macan EVP, GC, CCO and CS | STIM Neuronetics, Inc. | Sale | 1,541 | $0.82 | $1,264 Sale | Form 4 ↗ |
49 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 4:57 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances